Sectoral Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
3,323
-1,882
| -36% | -$614K | 0.72% | 46 |
|
|
2025
Q1 | $1.41M | Sell |
5,205
-3,095
| -37% | -$836K | 1.09% | 24 |
|
|
2024
Q4 | $1.95M | Sell |
8,300
-1,390
| -14% | -$327K | 1.3% | 22 |
|
|
2024
Q3 | $2.67M | Sell |
9,690
-2,790
| -22% | -$767K | 1.57% | 15 |
|
|
2024
Q2 | $3.03M | Sell |
12,480
-5,980
| -32% | -$1.45M | 1.23% | 23 |
|
|
2024
Q1 | $2.76M | Sell |
18,460
-4,180
| -18% | -$625K | 1.08% | 27 |
|
|
2023
Q4 | $4.33M | Sell |
22,640
-6,320
| -22% | -$1.21M | 1.87% | 13 |
|
|
2023
Q3 | $5.13M | Sell |
28,960
-866
| -3% | -$153K | 1% | 42 |
|
|
2023
Q2 | $5.67M | Buy |
29,826
+3,256
| +12% | +$618K | 0.94% | 45 |
|
|
2023
Q1 | $5.32M | Buy |
26,570
+3,760
| +16% | +$753K | 1.02% | 42 |
|
|
2022
Q4 | $5.42M | Buy |
22,810
+130
| +0.6% | +$30.9K | 1.05% | 41 |
|
|
2022
Q3 | $4.54M | Buy |
22,680
+10,650
| +89% | +$2.13M | 0.89% | 49 |
|
|
2022
Q2 | $1.76M | Buy |
12,030
+7,960
| +196% | +$1.16M | 0.35% | 83 |
|
|
2022
Q1 | $665K | Sell |
4,070
-3,526
| -46% | -$576K | 0.12% | 93 |
|
|
2021
Q4 | $1.29M | Sell |
7,596
-68,250
| -90% | -$11.6M | 0.19% | 92 |
|
|
2021
Q3 | $14.3M | Sell |
75,846
-2,000
| -3% | -$378K | 1.19% | 26 |
|
|
2021
Q2 | $13.2M | Sell |
77,846
-31,900
| -29% | -$5.41M | 1.07% | 35 |
|
|
2021
Q1 | $15.5M | Buy |
109,746
+1,400
| +1% | +$198K | 1.17% | 29 |
|
|
2020
Q4 | $14.1M | Buy |
+108,346
| New | +$14.1M | 0.99% | 41 |
|
|
2020
Q3 | – | Sell |
-17,600
| Closed | -$2.61M | – | 93 |
|
|
2020
Q2 | $2.61M | Sell |
17,600
-60,200
| -77% | -$8.92M | 0.24% | 72 |
|
|
2020
Q1 | $8.47M | Sell |
77,800
-9,800
| -11% | -$1.07M | 1.63% | 23 |
|
|
2019
Q4 | $10.1M | Sell |
87,600
-96,741
| -52% | -$11.1M | 1.51% | 28 |
|
|
2019
Q3 | $14.8M | Sell |
184,341
-218,300
| -54% | -$17.6M | 2.56% | 10 |
|
|
2019
Q2 | $29.2M | Buy |
402,641
+11,600
| +3% | +$842K | 3.49% | 6 |
|
|
2019
Q1 | $36.5M | Sell |
391,041
-104,300
| -21% | -$9.75M | 4.4% | 3 |
|
|
2018
Q4 | $36.1M | Buy |
495,341
+111,300
| +29% | +$8.11M | 4.91% | 3 |
|
|
2018
Q3 | $33.6M | Buy |
384,041
+80,341
| +26% | +$7.03M | 3.57% | 4 |
|
|
2018
Q2 | $29.9M | Buy |
+303,700
| New | +$29.9M | 3.34% | 6 |
|
|
2017
Q2 | – | Sell |
-24,899
| Closed | -$1.28M | – | 62 |
|
|
2017
Q1 | $1.28M | Buy |
24,899
+5,000
| +25% | +$256K | 0.15% | 56 |
|
|
2016
Q4 | $745K | Sell |
19,899
-5,901
| -23% | -$221K | 0.08% | 52 |
|
|
2016
Q3 | $1.75M | Buy |
25,800
+15,800
| +158% | +$1.07M | 0.17% | 53 |
|
|
2016
Q2 | $555K | Buy |
+10,000
| New | +$555K | 0.06% | 64 |
|